"Squawk Box." "But as more and more people get vaccinated or naturally infected, the pace of the variant is going to slow down and the virus is going to stabilize like you see with flu."The vaccines currently being rolled out across the U.S.
offer strong protection. But studies of experimental updates to the vaccines are critical if the virus eventually outsmarts today’s versions of the shots.
The Massachusetts-based Moderna hopes to submit its data to regulators within a few months, Bancel added."Our goal is to work really hard to get this ready before the fall," Bancel said. "I want to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and next winter season in the.